There are reports of a deal to lower the cost of obesity drugs, including GLP-1 medications like Ozempic, with some outlets stating that the cost will be reduced to $149 per month. Medicare is also set to cover these drugs for weight loss starting July 1. The details and implications of the plan, including its potential impact on costs and availability, are being discussed and analyzed by various parties.